Clinical Trials in Boston

Showing 6381-6400 of 17,836 trials

Pilot Trial of Contingency Management for Long-Term Cannabis Abstinence

NCT03786224

This study is a critically important first-of-its-kind investigation of the potential research utility of using contingency management to examine long-term changes in cannabis use with six months of abstinence. These pilot data will inform a later trial which will focus on testing the longitudinal relationships between adolescent cognition and cannabis use, questions of high and growing public health significance given adolescents' increased access to cannabis with legalization.

Cannabis UseAdolescent Behavior

Massachusetts General Hospital6 participantsStarted Jul 2019

Boston, Massachusetts, United States

COMPLETEDPhase 1/2< 1 mile

Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma

NCT01183949

The purpose of this study is to determine whether AT7519M alone or AT7519M plus bortezomib are effective treatments in patients with previously treated multiple myeloma.

Multiple Myeloma

Astex Pharmaceuticals, Inc.18 participantsStarted Nov 2010

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

Pilot Trial of Contingency Management for Long-Term Cannabis Abstinence

Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma

Find Trials by Condition in Boston

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

Improving Psychosocial Functioning in Older Veterans With PTSD

A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP

Neuropeptides in Human Reproduction

MCS110 With BRAF/MEK Inhibition in Patients With Melanoma

A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)

Zinc Intervention in Elderly for Prevention of Pneumonia

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

Episealer® Knee System IDE Clinical Study

Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.

Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD